In a significant move poised to accelerate the development of novel cancer treatments, global pharmaceutical giant Pfizer and leading Chinese…
Read More

In a significant move poised to accelerate the development of novel cancer treatments, global pharmaceutical giant Pfizer and leading Chinese…
Read More
Researchers from the Wellcome Sanger Institute, in collaboration with an international network of scientists, have unveiled the first comprehensive "blueprint"…
Read More
The mystery of why the vast majority of the human population—approximately 90%—favors the right hand has remained one of the…
Read More
Sai Life Sciences, a global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch Day…
Read More
The traditional understanding of the biological clock has long focused on maternal age, yet groundbreaking research published in the journal…
Read More
In a groundbreaking verdict that could reshape pharmaceutical antitrust litigation, a U.S. jury has found Japanese pharmaceutical giant Takeda liable…
Read More
Regeneron Pharmaceuticals has announced a monumental research collaboration with Parabilis Medicines, a deal valued at an impressive $2.32 billion. This…
Read More
The mystery of why the vast majority of the human population favors the right hand has remained one of the…
Read More
A pioneering research project led by the Wellcome Sanger Institute has fundamentally altered the scientific understanding of chronic myeloid leukemia…
Read More
Findings from the pivotal Phase III SURMOUNT-MAINTAIN trial, presented at the 33rd European Congress on Obesity (ECO) in Istanbul, Türkiye,…
Read More